Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril (1HAT)
Primary Purpose
Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Lisinopril
Hydrochlorothiazide
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension, Grade 1 focused on measuring hypertension, Blood Pressure control, hypertension treatment, antihypertensive, N of 1 study
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Grade 1 Hypertension
- Treatment naïve
- GFR > 60 within previous 3 months
- Urinary microalbumin level normal during previous 3 months
Exclusion Criteria:
- Pregnancy (Fetal morbidity and mortality may occur with the use of ACE inhibitors.)
- Uncontrolled Hyperthyroidism
- Sleep Apnea
- Primary Aldosteronism
- Renovascular Disease
- Cushing's Syndrome or steroid therapy
- No evidence of end organ damage
- EKG with evidence of LVH within previous 3 months
- Collagen Vascular Disease
- Current Smoker
Sites / Locations
- Scripps Clinic
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Lisinopril
Hydrochlorothiazide
Arm Description
Outcomes
Primary Outcome Measures
Blood pressure control defined as 24-hour ambulatory systolic and diastolic pressure average below 135/85 mmHg.
Secondary Outcome Measures
Blood Pressure (BP) load, treatment of non-dippers, side effects, and compliance.
BP load is defined as the percentage of ambulatory systolic and diastolic pressure exceeding 140 mmHg and 90 mmHg during the daytime and 120 mmHg and 80 mmHg during sleep. Systolic BP load averages 9-25% depending on age. While diastolic BP load averages 3-4%. Failure of BP to fall by at least 10 percent during sleep will define a non-dipper. Extreme dipping will be defined by a nocturnal BP decline of greater than 20 percent with a large morning increase in BP.
Full Information
NCT ID
NCT01258764
First Posted
December 9, 2010
Last Updated
May 19, 2015
Sponsor
Scripps Translational Science Institute
1. Study Identification
Unique Protocol Identification Number
NCT01258764
Brief Title
Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril
Acronym
1HAT
Official Title
Series of Single Patient Trials Comparing the Efficacy Between the Most Commonly Prescribed Thiazide Diuretic in the US, Hydrochlorothiazide, and Lisinopril for the Treatment of Stage 1 Hypertension.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Scripps Translational Science Institute
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this trial is to evaluate if an objective clinical decision of anti-hypertensive therapy can be made using an N-of-1 (single patient) trial design.
Detailed Description
Personalized medicine involves choosing the optimal treatment for a patient based on data gathered by the physician that is specific to that individual. The N-of-1 or single patient trial is a study design motivated by the new era of personalized medicine. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) recommends a personalized medicine approach to hypertensive drug class choice based on compelling indications. However, the hypertensive decision algorithm is limited. With the advent of new technology the amount of data available to a physician has grown substantially improving the robustness of surveying a more complete picture of the patient's health care status. Medicine is quickly becoming data intensive with new technology decreasing the cost of data collection and analysis.
The typical standard care for patients with stage 1 hypertension first involves a non-pharmacological modification of lifestyle changes. Health care providers diagnose hypertension when the blood pressure is persistently elevated after three to six visits over a several month period. JNC 7 recommends thiazide-type diuretics for Stage I hypertension for most patients. In the United States, this recommendation results in most patients being given a dose of hydrochlorothiazide (HCTZ) at 12.5 to 25 mg per day. A patient would then return for follow-up and would be prescribed a few month supply of an antihypertensive medication (e.g. HCTZ or lisinopril). The choice of treatment by the physician is based on JNC 7 guidelines, patient's risk factors, and a provider's experience.
The objective of this trial will be to evaluate if an objective clinical decision of anti-hypertensive therapy can be made using an N-of-1 (single patient) trial design. In this study we propose to do a series of N-of-1 trials in patients with stage 1 hypertension who will be randomized to alternating courses of HCTZ and lisinopril.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design, Hypertension
Keywords
hypertension, Blood Pressure control, hypertension treatment, antihypertensive, N of 1 study
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Lisinopril
Arm Type
Active Comparator
Arm Title
Hydrochlorothiazide
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Lisinopril
Other Intervention Name(s)
Prinivil, Zestril, ACE inhibitor
Intervention Description
Lisinopril 10 mg oral, once daily for four week cycle and a 2 week cycle
Intervention Type
Drug
Intervention Name(s)
Hydrochlorothiazide
Other Intervention Name(s)
Aquazide H, Carozide, Diaqua, Esidrix, Ezide, Hydro Par, HydroDIURIL, Hydrocot, Hydrokraft, Loqua, Oretic, Thiazide, HCTZ
Intervention Description
Hydrochlorothiazide 25 mg oral, once daily for 4 week cycle and a 2 week cycle
Primary Outcome Measure Information:
Title
Blood pressure control defined as 24-hour ambulatory systolic and diastolic pressure average below 135/85 mmHg.
Time Frame
After 14 week study period with assessment of patient specific data
Secondary Outcome Measure Information:
Title
Blood Pressure (BP) load, treatment of non-dippers, side effects, and compliance.
Description
BP load is defined as the percentage of ambulatory systolic and diastolic pressure exceeding 140 mmHg and 90 mmHg during the daytime and 120 mmHg and 80 mmHg during sleep. Systolic BP load averages 9-25% depending on age. While diastolic BP load averages 3-4%. Failure of BP to fall by at least 10 percent during sleep will define a non-dipper. Extreme dipping will be defined by a nocturnal BP decline of greater than 20 percent with a large morning increase in BP.
Time Frame
After 14 week study period with assessment of patient specific data
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of Grade 1 Hypertension
Treatment naïve
GFR > 60 within previous 3 months
Urinary microalbumin level normal during previous 3 months
Exclusion Criteria:
Pregnancy (Fetal morbidity and mortality may occur with the use of ACE inhibitors.)
Uncontrolled Hyperthyroidism
Sleep Apnea
Primary Aldosteronism
Renovascular Disease
Cushing's Syndrome or steroid therapy
No evidence of end organ damage
EKG with evidence of LVH within previous 3 months
Collagen Vascular Disease
Current Smoker
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bradley Patay, MD
Organizational Affiliation
Scripps Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Scripps Clinic
City
La Jolla
State/Province
California
ZIP/Postal Code
92037
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.Scripps.org
Description
Related Info
Learn more about this trial
Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril
We'll reach out to this number within 24 hrs